241 related articles for article (PubMed ID: 36429111)
1. Cell Dissemination in Pancreatic Cancer.
Kim J
Cells; 2022 Nov; 11(22):. PubMed ID: 36429111
[TBL] [Abstract][Full Text] [Related]
2. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
[TBL] [Abstract][Full Text] [Related]
3. The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer.
Kuwada K; Kagawa S; Yoshida R; Sakamoto S; Ito A; Watanabe M; Ieda T; Kuroda S; Kikuchi S; Tazawa H; Fujiwara T
J Exp Clin Cancer Res; 2018 Dec; 37(1):307. PubMed ID: 30537992
[TBL] [Abstract][Full Text] [Related]
4. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling.
Zhang Z; Xu Y
Mol Med; 2022 Jul; 28(1):82. PubMed ID: 35854234
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia Induces a HIF-1-Dependent Transition from Collective-to-Amoeboid Dissemination in Epithelial Cancer Cells.
Lehmann S; Te Boekhorst V; Odenthal J; Bianchi R; van Helvert S; Ikenberg K; Ilina O; Stoma S; Xandry J; Jiang L; Grenman R; Rudin M; Friedl P
Curr Biol; 2017 Feb; 27(3):392-400. PubMed ID: 28089517
[TBL] [Abstract][Full Text] [Related]
6. Response gene to complement-32 enhances metastatic phenotype by mediating transforming growth factor beta-induced epithelial-mesenchymal transition in human pancreatic cancer cell line BxPC-3.
Zhu L; Qin H; Li PY; Xu SN; Pang HF; Zhao HZ; Li DM; Zhao Q
J Exp Clin Cancer Res; 2012 Mar; 31(1):29. PubMed ID: 22458379
[TBL] [Abstract][Full Text] [Related]
7. The epithelial to mesenchymal transition in pancreatic cancer: A systematic review.
Beuran M; Negoi I; Paun S; Ion AD; Bleotu C; Negoi RI; Hostiuc S
Pancreatology; 2015; 15(3):217-25. PubMed ID: 25794655
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of LOXL2 in the promotion of pancreas cancer metastasis.
Park JS; Lee JH; Lee YS; Kim JK; Dong SM; Yoon DS
Oncotarget; 2016 Jul; 7(27):42539-42552. PubMed ID: 27285767
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?
Jiang JH; Liu C; Cheng H; Lu Y; Qin Y; Xu YF; Xu J; Long J; Liu L; Ni QX; Yu XJ
Biochim Biophys Acta; 2015 Jan; 1855(1):43-9. PubMed ID: 25432020
[TBL] [Abstract][Full Text] [Related]
10. PIK3R3 Promotes Metastasis of Pancreatic Cancer via ZEB1 Induced Epithelial-Mesenchymal Transition.
Peng YP; Zhu Y; Yin LD; Wei JS; Liu XC; Zhu XL; Miao Y
Cell Physiol Biochem; 2018; 46(5):1930-1938. PubMed ID: 29719293
[TBL] [Abstract][Full Text] [Related]
11. miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2.
Zhang Z; Che X; Yang N; Bai Z; Wu Y; Zhao L; Pei H
Biomed Pharmacother; 2017 Dec; 96():1341-1348. PubMed ID: 29196101
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of lncRNA AFAP1-AS1 by oridonin inhibits the epithelial-to-mesenchymal transition and proliferation of pancreatic cancer cells.
Lou S; Xu J; Wang B; Li S; Ren J; Hu Z; Xu B; Luo F
Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):814-825. PubMed ID: 31314060
[TBL] [Abstract][Full Text] [Related]
13. The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma.
Houg DS; Bijlsma MF
Mol Cancer; 2018 Jun; 17(1):95. PubMed ID: 29903049
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer metastasis: are we being pre-EMTed?
Das S; Batra SK
Curr Pharm Des; 2015; 21(10):1249-55. PubMed ID: 25506899
[TBL] [Abstract][Full Text] [Related]
15. HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer.
Yang J; Zhang X; Zhang Y; Zhu D; Zhang L; Li Y; Zhu Y; Li D; Zhou J
J Exp Clin Cancer Res; 2016 Feb; 35():26. PubMed ID: 26842802
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNA
Ko CC; Hsieh YY; Yang PM
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743003
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells.
Zhang JQ; Chen S; Gu JN; Zhu Y; Zhan Q; Cheng DF; Chen H; Deng XX; Shen BY; Peng CH
J Cell Biochem; 2018 Jan; 119(1):1027-1040. PubMed ID: 28685847
[TBL] [Abstract][Full Text] [Related]
18. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
[TBL] [Abstract][Full Text] [Related]
19. Arginine deprivation inhibits pancreatic cancer cell migration, invasion and EMT via the down regulation of Snail, Slug, Twist, and MMP1/9.
Wang H; Li QF; Chow HY; Choi SC; Leung YC
J Physiol Biochem; 2020 Feb; 76(1):73-83. PubMed ID: 31823303
[TBL] [Abstract][Full Text] [Related]
20. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
Meng F; Li W; Li C; Gao Z; Guo K; Song S
Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
